Francesco Maura

6.9k total citations
98 papers, 989 citations indexed

About

Francesco Maura is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Francesco Maura has authored 98 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 42 papers in Molecular Biology and 29 papers in Oncology. Recurrent topics in Francesco Maura's work include Multiple Myeloma Research and Treatments (61 papers), Protein Degradation and Inhibitors (23 papers) and Chronic Lymphocytic Leukemia Research (18 papers). Francesco Maura is often cited by papers focused on Multiple Myeloma Research and Treatments (61 papers), Protein Degradation and Inhibitors (23 papers) and Chronic Lymphocytic Leukemia Research (18 papers). Francesco Maura collaborates with scholars based in United States, Italy and United Kingdom. Francesco Maura's co-authors include Ola Landgren, Niccolò Bolli, Bachisio Ziccheddu, Antonino Neri, Gareth J. Morgan, Agostino Cortelezzi, Francesco Rodeghiero, Carlo Visco, Benjamin Diamond and Wilma Barcellini and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Francesco Maura

88 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesco Maura United States 18 580 496 315 229 212 98 989
Juan Flores‐Montero Spain 19 606 1.0× 423 0.9× 241 0.8× 169 0.7× 242 1.1× 42 1.0k
Zhenya Tang United States 20 456 0.8× 375 0.8× 335 1.1× 280 1.2× 139 0.7× 111 1.2k
Jeroen G. te Marvelde Netherlands 12 620 1.1× 361 0.7× 202 0.6× 109 0.5× 239 1.1× 20 1.0k
Anna van Rhenen Netherlands 13 696 1.2× 404 0.8× 408 1.3× 63 0.3× 300 1.4× 39 1.2k
James D. Cavenagh United Kingdom 17 901 1.6× 578 1.2× 391 1.2× 91 0.4× 267 1.3× 48 1.3k
Matteo Da Vià Italy 13 388 0.7× 281 0.6× 269 0.9× 127 0.6× 88 0.4× 34 738
Brian Parkin United States 16 374 0.6× 317 0.6× 212 0.7× 133 0.6× 200 0.9× 44 790
Hervé Dombret France 9 417 0.7× 281 0.6× 567 1.8× 243 1.1× 190 0.9× 14 1.1k
Luděk Pour Czechia 17 805 1.4× 682 1.4× 396 1.3× 110 0.5× 92 0.4× 109 1.1k
Anna Jankowska United States 15 494 0.9× 390 0.8× 185 0.6× 100 0.4× 188 0.9× 27 939

Countries citing papers authored by Francesco Maura

Since Specialization
Citations

This map shows the geographic impact of Francesco Maura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Maura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Maura more than expected).

Fields of papers citing papers by Francesco Maura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Maura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Maura. The network helps show where Francesco Maura may publish in the future.

Co-authorship network of co-authors of Francesco Maura

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Maura. A scholar is included among the top collaborators of Francesco Maura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Maura. Francesco Maura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saralamma, Venu Venkatarame Gowda, J.J.David Ho, Nikolai Fattakhov, et al.. (2025). Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell Immunotherapy. Cancer Research. 85(19). 3717–3736. 1 indexed citations
2.
Tauro, Marilena, Bachisio Ziccheddu, Alexandra M. Poos, et al.. (2024). Replication Stress Induces Hyper-Apobec Mutagenesis in Multiple Myeloma. Blood. 144(Supplement 1). 3276–3276.
3.
Kowalski, Andrew S., David G. Coffey, Benjamin Diamond, et al.. (2024). Comparison of Debulking Regimens (EPOCH and DCEP) for the Treatment of Relapsed or Refractory Multiple Myeloma. Blood. 144(Supplement 1). 2389–2389.
4.
Kazandjian, Dickran, Benjamin Diamond, Romanos Sklavenitis‐Pistofidis, et al.. (2024). Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma. Clinical Cancer Research. 30(19). 4482–4490. 5 indexed citations
5.
Saralamma, Venu Venkatarame Gowda, Marco Russo, Nikolai Fattakhov, et al.. (2024). Translational Disruption of NRF2 By Zotatifin Enhances Sensitivity to Ferroptosis and CAR-T Cells in Diffuse Large B-Cell Lymphoma. Blood. 144(Supplement 1). 4167–4167. 1 indexed citations
6.
Coughlin, Caroline A., Lingxiao Li, Evan R. Roberts, et al.. (2024). Decoding the Pivotal Roles of BCL10 Activating Mutations in DLBCL Drug Resistance and Lymphomagenesis. Blood. 144(Supplement 1). 829–829.
7.
Chojnacka, Monika, Benjamin Diamond, Bachisio Ziccheddu, et al.. (2023). Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma. Clinical Cancer Research. 30(3). 575–585. 1 indexed citations
8.
9.
10.
Tauro, Marilena, Bachisio Ziccheddu, Alexandra M. Poos, et al.. (2023). Genomic and Transcriptomic Landscape of Hyper-Apobec Multiple Myeloma. Blood. 142(Supplement 1). 639–639. 1 indexed citations
11.
Jain, Michael D., Bachisio Ziccheddu, Caroline A. Coughlin, et al.. (2022). Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma. Blood. 140(5). 491–503. 36 indexed citations
12.
Ziccheddu, Bachisio, Giulia Biancon, Chiara De Philippis, et al.. (2020). Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma. Blood Advances. 4(5). 830–844. 49 indexed citations
13.
D’Agostino, Mattia, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.. (2020). Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. Clinical Cancer Research. 26(18). 4832–4841. 38 indexed citations
14.
Maura, Francesco, Ola Landgren, & Gareth J. Morgan. (2020). Designing Evolutionary-based Interception Strategies to Block the Transition from Precursor Phases to Multiple Myeloma. Clinical Cancer Research. 27(1). 15–23. 15 indexed citations
15.
Yellapantula, Venkata D., Malin Hultcrantz, Even H. Rustad, et al.. (2020). Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma. Blood Cancer Journal. 10(1). 1 indexed citations
16.
Yellapantula, Venkata D., Malin Hultcrantz, Even H. Rustad, et al.. (2019). Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma. Blood Cancer Journal. 9(12). 101–101. 35 indexed citations
17.
Montefusco, Vittorio, Alberto Mussetti, Francesco Maura, et al.. (2017). Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients. Bone Marrow Transplantation. 52(12). 1602–1608. 14 indexed citations
18.
Castagna, Luca, Alberto Mussetti, Raynier Devillier, et al.. (2017). Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis. Biology of Blood and Marrow Transplantation. 23(9). 1549–1554. 23 indexed citations
19.
Bolli, Niccolò, Matteo Barcella, Erika Salvi, et al.. (2017). Next‐generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles. Cancer. 123(19). 3701–3708. 15 indexed citations
20.
Visco, Carlo, Francesco Maura, Giacomo Tuana, et al.. (2012). Immune Thrombocytopenia in Patients with Chronic Lymphocytic Leukemia Is Associated with Stereotyped B-cell Receptors. Clinical Cancer Research. 18(7). 1870–1878. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Flores‐Montero Breakdown of academic impact, for papers by Zhenya Tang Breakdown of academic impact, for papers by Jeroen G. te Marvelde Breakdown of academic impact, for papers by Anna van Rhenen Breakdown of academic impact, for papers by James D. Cavenagh Breakdown of academic impact, for papers by Matteo Da Vià Breakdown of academic impact, for papers by Brian Parkin Breakdown of academic impact, for papers by Hervé Dombret Breakdown of academic impact, for papers by Luděk Pour Breakdown of academic impact, for papers by Anna Jankowska
Rankless by CCL
2026